Findings from Situational Analyses of Asbestos-Related Diseases in the World



Similar documents
Epidemiology of Mesothelioma & Asbestos Diseases,

Emerging evidence that the ban on asbestos use is reducing the occurrence of pleural mesothelioma in Sweden


Mesothelioma Trends as Predictors of the Asbestos- Related Lung Cancer Burden

Estimating the Global Burden of Asbestos-related Diseases Using YPLL

Global mesothelioma deaths reported to the World. Health Organization between 1994 and 2008

Global Action on Prevention of Asbestos Diseases. Building and Woodworkers International - BWI

Changing Trends in Mesothelioma Incidence. Hans Weill, M.D. Professor of Medicine Emeritus Tulane University Medical Center

Occupational respiratory diseases due to Asbestos. Dirk Dahmann, IGF, Bochum

Worldwide mesothelioma mortality trends

Asbestos and Health WHO recommendations on elimination of asbestos-related diseases

Elimination of Asbestos- Related Diseases WHO action. Dr Ivan D. Ivanov Public Health and Environment WHO Headquarters

Asbestos Lessons learned from the EU. Alexandra Caterbow, Coordinator Chemicals and Health Women in Europe for a Common Future

PREVENTION OF OCCUPATIONAL DISEASES

Grassroots Asbestos Campaign in Asia. Sanjiv Pandita Asian Ban Asbestos Network Geneva,

Review of Eliminating occupational cancer in Europe and globally by J. Takala

Scientific Update on Safe Use of Asbestos. Robert P. Nolan, PhD International Environmental Research Foundation New York, New York

GLOBAL PANORAMA ON MESOTHELIOMA 2008

Estimation of Future Mortality From Pleural Malignant Mesothelioma in Japan Based on an Age-Cohort Model

COLLEGIUM RAMAZZINI THE GLOBAL HEALTH DIMENSIONS OF ASBESTOS AND ASBESTOS-RELATED DISEASES

NHS Barking and Dagenham Briefing on disease linked to Asbestos in Barking & Dagenham

ASBESTOS DISEASES. Dr Alastair Robertson

Health effects of occupational exposure to asbestos dust

Actuarial projections for mesothelioma: an epidemiological perspective Mark Clements, Geoffrey Berry and Jill Shi

PATTERNS OF MORTALITY IN ASBESTOS FACTORY WORKERS IN LONDON*

Asbestos related cancers

Future Trends of Mesothelioma Mortality in Japan Based on a Risk Function

MESOTHELIOMA IN AUSTRALIA INCIDENCE 1982 TO 2009 MORTALITY 1997 TO 2011

The Trend in Airborne Asbestos Concentrations at Plants Manufacturing Asbestos-Containing Products in Japan

Asbestos and the diseases it causes

Asbestos Clauses Workgroup

MESOTHELIOMA IN AUSTRALIA INCIDENCE 1982 TO 2008 MORTALITY 1997 TO 2007

Workers' Compensation in Japan

The Burden of Occupational Lung Cancer Paul A. Demers, PhD

Asbestos and Mesothelioma in Ontario

Mesothelioma in Australia: Incidence (1982 to 2013) and Mortality (1997 to 2012)

Current Usage and Health Significance of the Modern Use of Chrysotile Products: Review of Recently Published Evidence

Asbestos Exposure and the Continuing Burden of Asbestos Related Disease. Paul A. Demers Partners in Prevention April, 2014

How To Determine The Risk Of Mesothelioma In Brake Workers

Non-Communicable Diseases and Occupational Health Opportunities and Challenges

Are Current or Future Mesothelioma Epidemics in Hong Kong the Tragic Legacy of Uncontrolled Use of Asbestos in the Past?

The Belgian Asbestos Fund

Environmental Asbestos Exposure in Poland

Questions and Answers about the prevention of occupational diseases

A Cross-Sectional Study of Asbestos- Related Morbidity and Mortality in Vermonters Residing Near an Asbestos Mine November 3, 2008

NISG Asbestos. Caroline Kirton

Government responsibility for the already known carcinogen, Asbestos

The expected burden of mesothelioma mortality in Great Britain from 2002 to 2050

ANNEX 2: Assessment of the 7 points agreed by WATCH as meriting attention (cover paper, paragraph 9, bullet points) by Andy Darnton, HSE

Update of the scientific evidence on asbestos and cancer. Kurt Straif, MD MPH PhD. The IARC Monographs

Asbestos Health Risks. Dr Andrew Pengilley Acting Chief Health Officer

Outline for the Development of National Programmes for Elimination of Asbestos-Related Diseases

Kaiser Permanente Medical Group: Medical Legal Aspects of Mesothelioma

ASBESTOS. Know what it is and how you can protect yourself. environmental affairs Department: Environmental Affairs REPUBLIC OF SOUTH AFRICA

Asbestos: health effects and risk. Peter Franklin Senior Scientific Officer, EHD Senior Research Fellow, UWA

National Asbestos Profile Germany 2014

ASBESTOS MANAGEMENT REVIEW

Occupational Characteristics of Cases with Asbestosrelated Diseases in The Netherlands

- Compensation issues

Campaigning for Justice: On the Asbestos Frontline 2014

EFFECT OF CHILDREN'S AGE AND LIFE EXPECTATION ON MESOTHELIOMA RISK 1

The Human and Financial Burden of Asbestos in the WHO European Region. Meeting Report 5-6 November 2012, Bonn, Germany

The Damage by Asbestos and the Problems of Compensation/Relief in Japan. Kenichi Miyamoto

Malignant Mesothelioma Mortality --- United States,

How To Prevent Asbestos Related Diseases

Survey on the Mortality from Malignant Tumors of Female Asbestos Spinning Workers

Frequently Asked Questions. What is asbestos? 2. How is asbestos harmful? 2. What illnesses does asbestos cause? 3

Malignant Mesothelioma: an Update

Survey of Mesothelioma Associated with Asbestos Exposure in Japan

Introduced by Senator Miriam Defensor Santiago EXPLANATORY NOTE

THE AUSTRALIAN MESOTHELIOMA REGISTRY (AMR)

Frequently asked questions

The risks of mesothelioma and lung cancer in relation to relatively lowlevel exposures to different forms of asbestos

Combustion Engineering 524(g) Asbestos PI Trust Claim Form

Appendix. Appendix Figure 1: Trends in age-standardized cardiometabolic (CVD and diabetes) mortality by country.

Influence of Fiber Type, Size, and Number in Human Disease: Conclusions from Fiber Burden Analysis

Toxicity of Amphibole Asbestos

Sir William Osler: Listen to the patient; the patient tells you everything.

Asbestos Awareness Training

The Burden of Cancer in Asia

Lung cancer and asbestos

Malignant Mesothelioma in Australia,

(1) Comparison of studies with different follow-up periods

Preventive Measures to Eliminate Asbestos-Related Diseases in Singapore

Health Effects of Asbestos Exposure

ASBESTOS MANAGEMENT IN THE MIDDLE EAST. Charles Faulkner Asbestos Risk Management Consultant TEP Environmental Consultants

Asbestos-Related Cancer Research and Prevention

ASBESTOS ASBESTOS CANCER MESOTHELIOMA STAGING MESOTHELIOMA TREATMENT LUNG CANCER ASBESTOSIS PLEURAL DISEASE

Asbestos Diseases. What Is Asbestos?

Asbestos : the legacy remains and will still go on. Rob Armstrong Hawkes Bay District Health Board

FIGHTING FOR YOU. Asbestos and dust diseases

Mesothelioma mortality in Great Britain Summary 2. Overall scale of disease including trends 3. Region 6. Occupation 7

Asbestos and Industry - A Consultative Overview

Mathematical Modeling of Risk Acceptability Criteria

June 20, : Wagner Testimony on Workplace Exposure to Asbestos. This is an archive page. The links are no longer being updated.

Workers around the world who encounter hazardous substances are aware of the measures needed

Asbestos Trends Worldwide, with Richard Lemen

Lessons learned from the Western Australian experience with mesothelioma

Transcription:

ANZSOM2011 Wellington, NZ Findings from Situational Analyses of Asbestos-Related Diseases in the World University of Occupational & Environmental Health, Japan Acting Director of the WHOCC for Occupational Health Professor of Environmental Epidemiology Ken Takahashi

Current knowledge, on global scale WHO: >107,000 people die annually from asbestos-related lung cancer, mesothelioma and asbestosis resulting from occupational exposure [WHO Factsheet N343, July 2010] Driscoll: reported 43,000 mesothelioma deaths per year (2005); endorsed by WHO Estimated proportion of exposed workers, levels of exposure and absolute risk measures J Peto: landmark studies on mesothelioma epidemic (1995, 1999) triggered similar evaluation to form a genre

What we want to add Information Gaps across countries Global Situation, in depth Anticipate Future

Period Mortality Rate (PMR) of Pleural Mesothelioma, 1996-2005 (deaths/million/yr) 5DNK 12.9 1UK 31.1 2NLD 30.0 JPN 4.8 pmr (deaths/million/yr) 30 20-30 10 20 5 10 1 5 0 1 3AUS 25.5 4NZL 20.5 Nishikawa, Takahashi et al. Environ Health Perspect, 2008

Correlation at National Levels MORtality (2000-04) rates regressed on ASBestos (1960-69) use rates, weighted by POPulation All meso, male Pleural meso, male Peritoneal meso, male Asbestosis, male All mesothelioma, male: log 10 (MOR)=0.382 ASB-0.135 All mesothelioma, female: log 10 (MOR)=0.208 ASB-0.326 Lin RT, Takahashi K, et al. Lancet 2007; 369: 844-9 5

In numbers Historical consumption explains 74% of variation for mesothelioma and 79% of asbestosis (both p<.0001) Increment of 1 kg per capita corresponds to 2.4-fold increase in mesothelioma, 2.7- fold in asbestosis

From Relationship to Estimation Hidden Burden of Mesothelioma Data Blanks Countries report mesothelioma for variable years Cumulative Assess relation between asbestos use and reported mesothelioma Extrapolate Many developing countries do not report mesothelioma

Countries Grouped by Data Availability 1) WHO Mortality Database 2) USGS Database Mesothelioma 1) + - Asbestos 2) + - 56 33 11 * 100 83% world s population * Mostly territories with small populations

Stats for 2 Groups of 89 countries Data Availability Asbestos & Mesothelioma (N=56 countries) Asbestos only (N=33 countries) Asbestos use (tons) 1920-1970 51,200,000 14,200,000 1971-2007 52,800,000 71,300,000 Mesothelioma deaths (cases) WHO 91,265 0 Other sources* 868 0 Total 92,133 0 *Articles in English identified by Pubmed

15-year cumulative mortality of mesothelioma, cases (1994-2008) Adjusted R 2 = 0.83, p<0.0001 N=56 N=33 Cumulative asbestos use, metric ton (1920-1970) Park E-K, Takahashi K, et al. Environ Health Perspect, 2011)

Predicted 15-yr Cumulative N of Missed Mesothelioma Cases Cumulative Asbestos Use from 1920-1970 (ton) Predicted 15-yr Cumulative N of Mesothelioma from 1994-2008 (95% CI) Russia 8,443,923 21,308 (15,026 to 30,218) Kazakh 2,301,286 6,500 (5,006 to 8,440) China 1,767,086 5,107 (3,976 to 6,558) India 688,015 2,158 (1,700 to 2,739) Thailand 152,378 545 (400 to 741)

Findings on Global Mesothelioma Worldwide, 1 case is unreported for 4 to 5 reported cases (38,900 unreported vs. 174,300 reported) Total burden is 213,200 (1994-2008; 15 yr) or 14,200 annual cases under 5% growth Park EK, Takahashi K, et al. Environ Health Perspect, 2011

Concerns are Greater for Asia!

Kubota Shock of 2005 Japan Asbestos Panic 1 Asbestos-related Diseases Kubota Company Discloses 51 People Dead in 10 years 2 5 Residents Develop Mesothelioma Kubota to Compensate 2 Already Dead 2005.6.29 Mainichi Newspaper

Total Ban of Asbestos Effective Sep.1 2006 Prohibition of manufacture, import, sales, provision, use for products containing 0.1%+ weight of asbestos

Predicted Future Deaths, Male Pl. Mesothelioma (Japan) Murayama T, Takahashi K et al. Am J Ind Med, 2006

Effect on Residents Dose-response relation between SMRs of mesothelioma and asbestos concentarations Distribution of asbestos concentrations with places of residence for 96 mesothelioma victims. :plant Kurumatani & Kumagai. Am J Respir Crit Care Med (2008) 178: 624 629.

The National Story on Asbestos Déjà vu??

Asian Asbestos Initiative (AAI) Asian Forum for the Elimination of ARDs Represented by Academia and Administration at National Levels Share and Transfer of Preventative Technologies at primary, secondary and tertiary level Coordination with WHO, ILO, UNU-IIGH and UNEP-RCS AAI-1 (2008) Kitakyushu; AAI-2 (2009) BKK, Thailand; AAI-3 (2010) Fukuoka

New York Times June 21, 2011 Important Background is the COP-5, Rotterdam Convention Le GV, Takahashi K et al. Respirology 2011

Update of Global Situation 92,253 deaths (C45, ICD-10) identified in WHO Mortality Database,1994-2008 83 countries reported mesothelioma, of which 76 countries (88%) are high and middle income Mean age at death 70.0 yr (SD 11.6 yr) Minimal difference between gender Pleura (70.1 yr) > Peritoneum (66.0 yr) > Pericardium (61.1 yr) Crude mortality rate is 6.2 per million population; age-adjusted mortality rate is 4.9 per million population AAMR is Males (9.0 per Million) >> Females (1.9 per Million) Age-specific mortality rates increased sharply with age to exceed 100 per Million in elderly Vanya D, Takahashi K, et al. Bull World Health Organ, in press

Trends of reported mesothelioma AAMR increasing at +5% during past 15 yr Japan shows statistically significant increase at +3.5% USA shows statistically significant decrease at -0.8% Compound Interest 5% 15 yr >> 2-fold 23 yr >> 3-fold 29 yr >> 4-fold Vanya D, Takahashi K, et al. Bull World Health Organ

World Leaders Mortality rate <crude> <age-adjusted> 6.2/million/yr 4.9 /million/yr Change rate + 5 % Death Number (Reporting Yr) N (%) 1. USA (7) 17,062 18.5 2. UK (9) 13,517 14.6 3. Japan (14) 11,212 12.1 4. Germany (9) 9,569 10.4 5. France (8) 6,608 7.2 Mortality Rate (Reporting Yr) /million/yr 1. UK (9) 17.8 2. Australia (8) 16.5 3. Netherlands (13) 15.7 4. New Zealand (7) 13.0 5. Finland (13) 8.5 21. Japan (14) 3.3

Takahashi K. Occup Med (Oxford), 2008; Le GV, Takahashi K, Respirology, 2011

Burden of ARDs in Asia-Pacific & Globally, Conclusions National, regional and global situations are quantifiable with data from global databases Information gaps still exist for Asian (& PI) developing countries, but can be filled with improved recognition, diagnosis and reporting Anticipated future for Asia-Pacific is grim but obvious interventions can be a game changer

ANZSOM2011 Wellington, NZ Findings from Situational Analyses of Asbestos-Related Diseases in the World University of Occupational & Environmental Health, Japan Acting Director of the WHOCC for Occupational Health Professor of Environmental Epidemiology Ken Takahashi

Dept. Environ Epidemiol, IIES, UOEH (Japan) R-T. Lin K. Nishikawa V. Delgermaa E-K. Park G-V. Le

*corresponding author 1. Vanya D, Takahashi K* et al. Global trends in mortality caused by mesothelioma, 1994-2008. Bull World Health Organ, in press. 2. Le GV, Takahashi K* et al. Asbestos use and asbestos-related diseases in Asia: past, present and future. Respirology 2011, 16:767-75. 3. Park EK, Takahashi K* et al. Global magnitude of reported and unreported mesothelioma. Environ Health Perspect, 2011, 119: 514-8. 4. Takahashi K and Kang S-K. Towards elimination of asbestos-related diseases: a theoretical basis for international cooperation. Safety Health Work 2010, 1:103-6. 5. Le GV, Takahashi K* et al. National use of asbestos in relation to economic development. Environ Health Perspect 2010, 118(1):116-9. 6. Takahashi K. Asbestos-related diseases: time for technology sharing (editorial). Occup Med (London) 2008, 58:384-385. 7. Nishikawa K, Takahashi K* et al. Recent mortality from pleural mesothelioma, historical patterns of asbestos use, and adoption of bans: a global assessment. Environ Health Perspect 2008, 116:1675-1680. 8. Lin R-T, Takahashi K* et al. Ecological association between asbestos-related diseases and historical asbestos consumption: an international analysis. Lancet 2007, 369:844-849. 9. Murayama T, Takahashi K et al. Estimation of future mortality from pleural malignant mesothelioma in Japan based on an age-cohort model. Am J Ind Med 2006, 49: 1-7. 10. Takahashi K and Karjalainen A. A cross-country comparative overview of the asbestos situation in ten Asian countries. Int J Occup Environ Health 2003, 9(3):244-8.

Homepage http://envepi.med.uoeh-u.ac.jp/acoh/ 21 st ACOH Meeting in September, 2014 20 th 2011 Thailand 19 th 2008 Singapore 18 th 2005 New Zealand 17 th 2002 Taiwan 16 th 1999 Philippines 15 th 1997 Malaysia

The Economic Argument Isn t Asbestos Doing Any Good? Economic argument is incapable of incorporating future disease burden (40 yr!) All ARDs are preventable Safer (and economically viable) substitutes exist AC waterpipes ductile iron, high-density polyethylene, wire-reinforced concrete pipes AC construction material (roofs & walls) replace ASB with polyvinyl alcohol fiber and cellulose fiber

All Reported Mesothelioma, World Average death age 70.0±11.6 yr Male-to-female ratio 3.6 Anatomical Site % Pleura(C45.0) 41% Peritoneum(C45.1) 5% Pericardium(C45.2) 0.3% Others(C45.7) 7% Unspecified(C45.9) 43%

ACOH2011 Bangkok Burden of Asbestos-Related Diseases in Asia and Globally University of Occupational & Environmental Health, Japan Acting Director of the WHOCC for Occupational Health Professor of Environmental Epidemiology Ken Takahashi

Chronology of Laws and Regulations ISHL=Industrial Safety & Health Law; its enforcement order (EO); its ordinance Ordinance*=on Prevention of Hazards Due to Specified Chemical Substances 1971 (S46) 1975 (S50) 1995 (H07) 1996 (H08) 2004 (H16) 2005 (H17) Ordinance* enforced: regulated as Group 2 Substance (prevention of leakage; appointment of Operations Chief; implementation of Work Environment Measurement) Ordinance* amended: asbestos spraying is prohibited; implementation of Specific Medical Examination for asbestos-handling workers (on placement and every 6 mo.) EO (ISHL) amended: prohibition of crocidolite and amosite Ordinance amended: PPE mandated for designated jobs; reinforcement of regulatory procedures for removal of sprayed asbestos Health Administration Diary distributed and Medical Examination provided to retired workers who handled asbestos under a particular condition EO(ISHL) amended: chrysotile prohibited in principle (construction material, abrasive material, etc.) Ordinance on Prevention of Asbestos Hazards separated from Ordinance*

Asbestos Use vs. Economic Development, WORLD 10 Environmental Kuznets Curve 1 0.1 GDP per capita --x-- High Income --x-- Middle Income --x-- Low Income --x-- Others 0.05 0 5,000 10,000 15,000 20,000 25,000 30,000 GDP per capita (1990 GK dollars) Le GV, Takahashi K et al. Environ Health Perspect, 2010